A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

NEC has developed a system to use face biometrics to authenticate patients for personalized cancer vaccine therapy without ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

Cervical cancer rates are on the rise among younger women, owing in part to a lack of screening and prevention.

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

Full-year results and business updateClinical proof of principle obtained in Phase I adjuvant head and neck cancer trial with individualized ...

In their messages during Eid al-Fitr prayers yesterday, key preachers also touched on social issues ranging from the ...

SEATTLE, April 1, 2025 /PRNewswire/ -- In Concert for Cancer's 14th annual benefit concert brings star power to Seattle's ...

Glenn Moog didn't know much about HPV cancer — until he was diagnosed with it. The 59-year-old husband, father and realtor ...

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine. Anixa Biosciences, Inc. March 24, 2025.